JP2023521167A5 - - Google Patents

Info

Publication number
JP2023521167A5
JP2023521167A5 JP2022562023A JP2022562023A JP2023521167A5 JP 2023521167 A5 JP2023521167 A5 JP 2023521167A5 JP 2022562023 A JP2022562023 A JP 2022562023A JP 2022562023 A JP2022562023 A JP 2022562023A JP 2023521167 A5 JP2023521167 A5 JP 2023521167A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
cyclobenzaprine
composition according
item
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022562023A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023521167A (ja
JP7780447B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/026492 external-priority patent/WO2021207561A1/en
Publication of JP2023521167A publication Critical patent/JP2023521167A/ja
Publication of JP2023521167A5 publication Critical patent/JP2023521167A5/ja
Priority to JP2025172812A priority Critical patent/JP2025185159A/ja
Application granted granted Critical
Publication of JP7780447B2 publication Critical patent/JP7780447B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022562023A 2020-04-08 2021-04-08 性機能障害のシクロベンザプリン処置 Active JP7780447B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025172812A JP2025185159A (ja) 2020-04-08 2025-10-14 性機能障害のシクロベンザプリン処置

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063007251P 2020-04-08 2020-04-08
US63/007,251 2020-04-08
PCT/US2021/026492 WO2021207561A1 (en) 2020-04-08 2021-04-08 Cyclobenzaprine treatment for sexual dysfunction

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025172812A Division JP2025185159A (ja) 2020-04-08 2025-10-14 性機能障害のシクロベンザプリン処置

Publications (3)

Publication Number Publication Date
JP2023521167A JP2023521167A (ja) 2023-05-23
JP2023521167A5 true JP2023521167A5 (enExample) 2024-04-22
JP7780447B2 JP7780447B2 (ja) 2025-12-04

Family

ID=75675042

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022562023A Active JP7780447B2 (ja) 2020-04-08 2021-04-08 性機能障害のシクロベンザプリン処置
JP2025172812A Pending JP2025185159A (ja) 2020-04-08 2025-10-14 性機能障害のシクロベンザプリン処置

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025172812A Pending JP2025185159A (ja) 2020-04-08 2025-10-14 性機能障害のシクロベンザプリン処置

Country Status (7)

Country Link
US (1) US20210315841A1 (enExample)
EP (1) EP4132648A1 (enExample)
JP (2) JP7780447B2 (enExample)
CN (1) CN115803088B (enExample)
AU (1) AU2021253592A1 (enExample)
CA (1) CA3179754A1 (enExample)
WO (1) WO2021207561A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023059728A1 (en) * 2021-10-06 2023-04-13 Tonix Pharmaceuticals Holding Corp. Cyclobenzaprine for treatment or prevention of sexual dysfunction associated with mental health conditions in female patients
US12370198B2 (en) 2022-07-08 2025-07-29 La Pharmatech Inc Pharmaceutical compositions and methods for treating psychiatric disorders
KR20250086333A (ko) * 2023-12-06 2025-06-13 삼진제약주식회사 약학적 제제 및 이의 제조방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI242011B (en) 1997-03-31 2005-10-21 Eisai Co Ltd 1,4-substituted cyclic amine derivatives
BR0013017A (pt) * 1999-08-13 2002-04-16 Vela Pharmaceuticals Inc Usos de composições para o tratamento ou prevenção dos distúrbios do sono usando doses muito baixas de ciclobenzaprina
US6855324B2 (en) * 2000-11-20 2005-02-15 Adrian Sandler Therapeutic placebo enhancement of commonly-used medications
US20060264511A1 (en) * 2005-05-19 2006-11-23 Boehringer Ingelheim International Gmbh Method for the treatment of drug-induced sexual dysfunction
SMT201700578T1 (it) * 2009-11-20 2018-01-11 Tonix Pharma Holdings Ltd Metodo e composizioni per trattare i sintomi associati al disturbo da stress post-traumatico usando ciclobenzaprina
SG10201609297VA (en) 2011-04-04 2016-12-29 S1 Biopharma Inc Treatment regimens
RS63822B1 (sr) * 2012-06-15 2023-01-31 Tonix Pharma Holdings Ltd Kompozicije i postupci za transmukoznu apsorpciju
SMT202400324T1 (it) * 2013-03-15 2024-11-15 Tonix Pharma Ltd Formulazioni eutettiche di ciclobenzaprina cloridrato e mannitolo
MY186047A (en) 2014-09-18 2021-06-17 Tonix Pharma Holdings Ltd Eutectic formulations of cyclobenzaprine hydrochloride
JP2018512450A (ja) * 2015-03-19 2018-05-17 ウェンディ アン エプスタインＥＰＳＴＥＩＮ， Ｗｅｎｄｙ Ａｎｎｅ 女性の性的障害を治療するための化合物及び剤型
BR112019010077A2 (pt) * 2016-11-22 2019-10-01 Alkalidx Inc terapias para o tratamento de condições hipocalêmicas e de ineficácia da lidocaína
MX2020006140A (es) 2017-12-11 2020-08-13 Tonix Pharma Holdings Ltd Tratamiento con ciclobenzaprina para la agitacion, psicosis y deterioro cognitivo en la demencia y enfermedades neurodegenerativas.
US20220117915A1 (en) 2018-08-20 2022-04-21 Tonix Pharma Holdings Limited Methods of treating acute stress disorder and posttraumatic stress disorder
US11337937B2 (en) * 2018-08-27 2022-05-24 ReJoy TARR receptor agonists for sexual dysfunction

Similar Documents

Publication Publication Date Title
JP2023521167A5 (enExample)
JP2025185159A (ja) 性機能障害のシクロベンザプリン処置
JP5991988B2 (ja) 子宮内膜基底層の剥脱に関する疼痛の治療
JP4880031B2 (ja) 全般性不安障害の処置に用いる医薬を製造するためのアゴメラチンの使用
KR100706727B1 (ko) 중증 심부전의 치료방법 및 이를 위한 약제
JP2002523366A (ja) ドーパミン再取込みインヒビターを含有する組成物及びその使用方法
TW201936567A (zh) 發炎性疾病或骨病之預防或治療劑及醫藥組成物
JP2008540672A (ja) 病状に起因する性的機能不全の治療方法
EP3645120B1 (en) Nk-1 antagonist compositions and methods for use in treating depression
JP2020523355A (ja) 肉腫を処置することへの使用のためのチノスタムスチン
JP5298334B2 (ja) 性機能障害を治療する方法
CN1262622A (zh) 调节人性反应的联合治疗
CN101194901A (zh) 阿戈美拉汀在制备用于治疗Smith-Magenis综合征的药物中的用途
US8101580B2 (en) Therapeutic agent for irritable bowel syndrome
CN102781437B (zh) 阿戈美拉汀在得到预定治疗强迫性障碍(ocd)的药物中的用途
Marinho et al. Behçet's syndrome: literature review and clinical case report
HK40090080A (zh) 性功能障碍的环苯扎林治疗
HK40090080B (zh) 性功能障碍的环苯扎林治疗
JPWO2020080451A1 (ja) 糖尿病腎症における腎線維化抑制剤
JP2004529850A (ja) 性機能不全の処置および防止のための方法および組成物
US20250090528A1 (en) Use of complement factor d inhibitor for treatment of lupus nephritis and immunoglobulin a nephropathy
US10022389B2 (en) Prophylactic or therapeutic drug for constipation
US20240415789A1 (en) Cyclobenzaprine for treatment or prevention of sexual dysfunction associated with mental health conditions in female patients
US20240238290A1 (en) Use of complement factor d inhibitor for treatment of generalized myasthenia gravis
WO2025245066A1 (en) Compositions and methods for affecting weight loss, weight management, sexual disorders, well-being, self-esteem, and/or self-confidence